Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5301
CALL
Corvus Pharmaceuticals
CRVS
$1.12B
| $499K | ﹤0.01% |
+103,100
| New | +$305K |
|
|
AVAN
5302
CALL
DELISTED
Avanti Acquisition Corp.
AVAN
| $499K | ﹤0.01% |
763,488
+3,134
| +0.4% | +$30.5K |
|
5303
New Fortress Energy
NFE
$92.1M
| $498K | ﹤0.01% |
17,955
+3,641
| +25% | +$110K |
|
5304
Redwire
RDW
$2.06B
| $498K | ﹤0.01% |
51,719
-244,469
| -83% | -$2.55M |
|
5305
QCR Holdings
QCRH
$1.69B
| $497K | ﹤0.01% |
+9,660
| New | +$477K |
|
|
BCLI
5306
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $496K | ﹤0.01% |
10,022
-14,742
| -60% | -$776K |
|
5307
CALL
Aurora
AUR
$12.6B
| $495K | ﹤0.01% |
329,710
-67,855
| -17% | -$671K |
|
5308
Super Micro Computer
SMCI
$18.4B
| $494K | ﹤0.01% |
+135,200
| New | +$490K |
|
5309
iShares 0-5 Year TIPS Bond ETF
STIP
$15.9B
| $494K | ﹤0.01% |
+4,672
| New | +$496K |
|
|
LUCK
5310
CALL
Lucky Strike Entertainment
LUCK
$914M
| $494K | ﹤0.01% |
358,332
+241,666
| +207% | +$2.39M |
|
5311
PG&E
PCG
$38.3B
| $493K | ﹤0.01% |
51,360
-88,176
| -63% | -$832K |
|
|
FBMS
5312
DELISTED
The First Bancshares, Inc.
FBMS
| $493K | ﹤0.01% |
12,723
+1,612
| +15% | +$62.2K |
|
5313
CALL
Nucor
NUE
$58.6B
| $492K | ﹤0.01% |
5,000
-45,500
| -90% | -$4.84M |
|
5314
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$304M
| $492K | ﹤0.01% |
26,803
-6,773
| -20% | -$119K |
|
5315
Chesapeake Utilities
CPK
$3.19B
| $491K | ﹤0.01% |
4,086
+971
| +31% | +$122K |
|
5316
Maui Land & Pineapple Co
MLP
$344M
| $491K | ﹤0.01% |
47,368
-38,907
| -45% | -$416K |
|
5317
PUT
Navient
NAVI
$789M
| $491K | ﹤0.01% |
24,900
-100,000
| -80% | -$2.15M |
|
5318
PUT
Weyerhaeuser
WY
$18B
| $491K | ﹤0.01% |
+13,800
| New | +$483K |
|
5319
iShares MSCI USA Momentum Factor ETF
MTUM
$25B
| $490K | ﹤0.01% |
+2,789
| New | +$496K |
|
|
SEPAU
5320
DELISTED
SEP Acquisition Corp Unit
SEPAU
| $490K | ﹤0.01% |
+48,750
| New | +$485K |
|
5321
MiMedx Group
MDXG
$602M
| $489K | ﹤0.01% |
+80,696
| New | +$910K |
|
5322
Weyco Group
WEYS
$372M
| $488K | ﹤0.01% |
21,533
-41,351
| -66% | -$950K |
|
5323
Carlisle Companies
CSL
$14.3B
| $487K | ﹤0.01% |
2,452
-20,949
| -90% | -$4.23M |
|
|
NM
5324
DELISTED
Navios Maritime Holdings Inc.
NM
| $487K | ﹤0.01% |
102,091
+83,525
| +450% | +$419K |
|
|
NGCA
5325
CALL
DELISTED
NextGen Acquisition Corp. II Class A Ordinary Shares
NGCA
| $487K | ﹤0.01% |
290,000
+90,000
| +45% | +$891K |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.